Response to Office Action

PTO- 1957

Approved for use through 11/30/2023. OMB 0651-0050

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1957

Approved for use through 11/30/2023. OMB 0651-0050

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Response to Office Action

To the Commissioner for Trademarks:

Application serial no. 90349390 VUITY (Stylized and/or with Design, see http://tmng-al.uspto.gov /resting2/api/img/9034939 0/large) has been amended as follows:

MARK
Applicant proposes to amend the mark as follows:
Current: VUITY (Stylized and/or with Design, see http://tmng-al.uspto.gov /resting2/api/img/9034939 0/large)
Proposed: VUITY (Stylized and/or with Design, see mark)
The applicant is not claiming color as a feature of the mark.
The mark consists of a stylized circle broken into four parts with the word "VUITY" to the right of the circle.

The owner's/holder's proposed attorney information: Cheryl A. Withycombe. Other appointed attorneys are Matthew O. Brady. Cheryl A. Withycombe of AbbVie Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at

      2525 Dupont Dr.
      Irvine, California 92612
      United States
is appointed to submit this Response to Office Action Form on behalf of the applicant.
The docket/reference number is VUITY Logo.
      The phone number is 847-937-3386.
      The fax number is 847-938-2623.
      The email address is cheryl.withycombe@abbvie.com

Cheryl A. Withycombe submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.Correspondence Information (current):
      ALLERGAN SALES, LLC
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@abbvie.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kimberly.gleason@abbvie.com; matthew.brady@allergan.com; trademarks@abbvie.com

The docket/reference number is VUITY LOGO.
Correspondence Information (proposed):
      Cheryl A. Withycombe
      PRIMARY EMAIL FOR CORRESPONDENCE: cheryl.withycombe@abbvie.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): trademarks@abbvie.com

The docket/reference number is VUITY Logo.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

SIGNATURE(S)
Response Signature
Signature: /Cheryl A. Withycombe/     Date: 08/09/2021
Signatory's Name: Cheryl A. Withycombe
Signatory's Position: Attorney of record, CA bar member

Signatory's Phone Number: 847-937-3386 Signature method: Signed directly within the form

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

Mailing Address:    ALLERGAN SALES, LLC
   
   
   5 GIRALDA FARMS
   MADISON, New Jersey 07940
Mailing Address:    Cheryl A. Withycombe
   AbbVie Inc.
   2525 Dupont Dr.
   Irvine, California 92612
        
Serial Number: 90349390
Internet Transmission Date: Tue Aug 10 01:49:55 ET 2021
TEAS Stamp: USPTO/ROA-XX.XXX.XX.XXX-2021081001495502
9432-90349390-781a12cbb37e579d3da42b04b5
b4a6397ef4dc471569bee9524d5943278ac068f-
N/A-N/A-20210810013331650313